Tiffany Khong

Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma

Sridurga Mithraprabhu, Anna Kalff, Annie Chow et al. · Epigenetics · 2014 · 176 citations · Full text

Hematological Malignancy, Tumor Biology, Chromatin +14

Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition

Simon J. Hogg, Olga Motorna, Leonie A. Cluse et al. · Molecular Cell · 2021 · 157 citations · Full text

Hierarchy for targeting prosurvival BCL2 family proteins in multiple myeloma: pivotal role of MCL1

Jia-Nan Gong, Tiffany Khong, David Segal et al. · Blood · 2016 · 141 citations · Full text

Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma

Sridurga Mithraprabhu, Tiffany Khong, Malarmathy Ramachandran et al. · Leukemia · 2016 · 107 citations

Hematological Malignancy, Disease Relapse, Oncology +12

The novel JAK inhibitor CYT387 suppresses multiple signalling pathways, prevents proliferation and induces apoptosis in phenotypically diverse myeloma cells

Katherine Monaghan, Tiffany Khong, Christopher J. Burns et al. · Leukemia · 2011 · 82 citations

Hematological Malignancy, Tumor Biology, Prevents Proliferation +11